DEPROMP Trial: the additive value of PSMA-PET/CT-guided biopsy for prostate cancer management in biopsy naïve men—study protocol for a randomized trial

被引:0
作者
P. Krausewitz
R. A. Bundschuh
F. C. Gaertner
M. Essler
U. Attenberger
J. Luetkens
G. Kristiansen
M. Muders
C-H. Ohlmann
S. Hauser
J. Ellinger
M. Ritter
机构
[1] University Hospital Bonn,Department of Urology and Pediatric Urology
[2] University Hospital Bonn,Department of Nuclear Medicine
[3] University Hospital Bonn,Department of Diagnostic and Interventional Radiology
[4] Institute of Pathology,Department of Urology
[5] University Hospital Bonn,undefined
[6] Johanniter Hospital Bonn,undefined
来源
Trials | / 24卷
关键词
PSMA-PET/CT; Prostate biopsy; Management plan; Clinically significant prostate cancer; Multiparametric MRI;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 150 条
[1]  
Roth AJ(2008)Prostate cancer: psychosocial implications and management Future Oncol 4 561-568
[2]  
Weinberger MI(2022)Prospective analysis of pain expectancy and experience during MR-fusion prostate biopsy: does reality match patients’ expectancy? World J Urol 389 815-822
[3]  
Nelson CJ(2017)Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Lancet 79 243-262
[4]  
Krausewitz P(2021)EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, diagnosis, and local treatment with curative intent Eur Urol 4 CD012663-928
[5]  
Schmeller H(2019)Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer Cochrane Database Syst Rev 382 917-2363
[6]  
Luetkens J(2020)MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis N Engl J Med 22 2354-S18
[7]  
Dabir D(2013)Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer Cancer Epidemiol Biomarkers Prev 6 S13-1216
[8]  
Ellinger J(2004)Overview of prostate-specific membrane antigen Rev Urol 395 1208-215
[9]  
Ritter M(2020)Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study Lancet 119 209-103
[10]  
Conrad R(2017)Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer BJU Int 200 95-90